melanoma

2017 ASCO Annual Meeting. #ASCO17
June 3, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.

Read More >>
February 21, 2017
Lindsay Dudbridge, ASCO staff

Highlights from the 2017 Clinical Immuno-Oncology Symposium

English
lindsay.dudbridge

At the 2017 Clinical Immuno-Oncology Symposium, new research will be presented on the link between gut bacteria and immunotherapy for melanoma and the impact of tumor location in predicting survival from colorectal cancer.

Read More >>
2017 Clinical Cancer Advances
February 1, 2017
Greg Guthrie, ASCO staff

Immunotherapy 2.0: The 2017 Clinical Cancer Advance of the Year

English
gregguthrie

The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.

Read More >>
October 27, 2015
Cat Snyder, ASCO staff

FDA Approval for Melanoma Treatment

English
catherine.snyder

Paul Chapman, MD, discusses the current treatments for metastatic melanoma and the direction of current research.

Read More >>

Pages

Subscribe to RSS - melanoma